ChinaBio® Investor Forum

July 7-8, 2008 | Shanghai, China

Connecting entrepreneurs and investors in China biotech™

China is the fastest growing market for pharmaceuticals in the world. Now, after billions of dollars of investment, China is transforming itself into a world leader in biotech innovation, and will soon be the 2nd largest market after the U.S.In just one year, VC investment in China biotech has increased 400%.

Last year, the ChinaBio® Investor Forum attracted over 150 attendees and 50 VCs from the life science industry.  Fifteen companies presented their business plans and most received VC investments as a result.  VCs in attendance included Bay City Capital, BioVeda China, HBM BioMed, Mingly China Growth Fund, Morningside, Sequoia Capital, Sofinnova, and more.

This year, ChinaBio® Investor Forum 2008 - Shanghai will host even more early stage biotechnology, diagnostics and services companies developing novel technologies and addressing unmet needs.  Attendees will have the opportunity to screen these companies in a rapid two-day forum that also offers educational sessions on the state of the biotechnology industry and VC investment in China. 

So join us at the ChinaBio® Investor Forum in Shanghai on July 7-8 to see the best early stage life science companies in China, or to present your company to more than 50 top tier VCs from around the world.

Why Attend:

·Meet early and mid-stage companies seeking investment

·Connect with VCs and other investors from the US and China

·Understand the opportunities and challenges of the biotech industry in China

· Network with other entrepreneurs, industry executives and investors

Who Should Attend:

·U.S. & China VCs, fund managers and angel investors

·Global pharma executives and business development managers

·China biotech entrepreneurs

·Industry analysts, media, etc.

Format:

·Two days packed with company presentations and informative sessions

·Keynote speakers and panelists give insights and analysis of the China biotech industry

·Entrepreneurs present business plans and then meet face-to-face in breakout sessions

·Multiple networking opportunities including the popular dinner reception on July 7

·Top companies receive “Most Promising” Awards in the ceremony held on July 8

Topics:

·State of China Biotech – where is biotech going in China and Zhangjiang Hi-Tech Park?

·Challenging Investment Climate – address the legal and policy issues facing investors and entrepreneurs

·Funding success stories – hear successful entrepreneurs and VCs tell their stories

·          Partnering in China Biotech – meet pharma and service execs willing to partner with you

Location: